SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

72,351.04 757.80
( 1.06%)

Global Indices

Nasdaq

51,245.91 45.04
(0.09%)

Dow Jones

7,786.38 -36.39
(-0.47%)

Hang Seng

69,343.08 -692.63
(-0.99%)

Nikkei 225

10,441.54 -16.96
(-0.16%)

Forex

USD-INR

96.67 0.30
(0.31%)

EUR-INR

108.31 -0.02
(-0.02%)

GBP-INR

127.86 0.18
(0.14%)

JPY-INR

0.61 0.00
(0.24%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Lupin Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

500257

INE326A01037

658.9645485

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

LUPIN

13.41

88805.71

EPS(TTM)

Face Value()

Div & Yield %

144.8

0.93

Back

Strides Pharma Science consolidated net profit rises 57.52% in the June 2026 quarter

Jul 31,2026

Net profit of Strides Pharma Science rose 57.52% to Rs 156.91 crore in the quarter ended June 2026 as against Rs 99.61 crore during the previous quarter ended June 2025. Sales rose 13.01% to Rs 1265.41 crore in the quarter ended June 2026 as against Rs 1119.74 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	1265.41	1119.74	13
OPM %	18.06	19.48	-
PBDT	192.82	179.30	8
PBT	136.42	130.41	5
NP	156.91	99.61	58

72,351.04 757.80 ( 1.06%)

51,245.91 45.04 (0.09%)

7,786.38 -36.39 (-0.47%)

69,343.08 -692.63 (-0.99%)

10,441.54 -16.96 (-0.16%)

96.67 0.30 (0.31%)

108.31 -0.02 (-0.02%)

127.86 0.18 (0.14%)

0.61 0.00 (0.24%)